Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.

Overview of attention for article published in Clinical Cancer Research, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Effect of Bevacizumab in Patients with Advanced Ovarian Cancer and Low VEGF-A165b Expression

Physician's Weekly, 25 Nov 2022

Ovarian cancer patients would greatly benefit from the discovery of a reliable IHC marker that could predict their response to…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.